China · Delayed Price · Currency is CNY Lifecome Biochemistry Statistics
Total Valuation
SHE:002868 has a market cap or net worth of CNY 6.24 billion. The enterprise value is 6.52 billion.
| Market Cap | 6.24B |
| Enterprise Value | 6.52B |
Important Dates
The last earnings date was Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:002868 has 155.42 million shares outstanding. The number of shares has decreased by -0.54% in one year.
| Current Share Class | 155.42M |
| Shares Outstanding | 155.42M |
| Shares Change (YoY) | -0.54% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 23.63% |
| Owned by Institutions (%) | 5.04% |
| Float | 90.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.41 |
| PB Ratio | 87.77 |
| P/TBV Ratio | 128.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 136.61, with an EV/FCF ratio of -40.70.
| EV / Earnings | -62.80 |
| EV / Sales | 12.95 |
| EV / EBITDA | 136.61 |
| EV / EBIT | n/a |
| EV / FCF | -40.70 |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 5.18.
| Current Ratio | 0.58 |
| Quick Ratio | 0.38 |
| Debt / Equity | 5.18 |
| Debt / EBITDA | 7.51 |
| Debt / FCF | -2.30 |
| Interest Coverage | -0.90 |
Financial Efficiency
Return on equity (ROE) is -1,189.13% and return on invested capital (ROIC) is -11.22%.
| Return on Equity (ROE) | -1,189.13% |
| Return on Assets (ROA) | -2.72% |
| Return on Invested Capital (ROIC) | -11.22% |
| Return on Capital Employed (ROCE) | -13.65% |
| Weighted Average Cost of Capital (WACC) | 10.14% |
| Revenue Per Employee | 916,115 |
| Profits Per Employee | -188,973 |
| Employee Count | 549 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 5.03 |
Taxes
In the past 12 months, SHE:002868 has paid 1.46 million in taxes.
| Income Tax | 1.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +189.47% in the last 52 weeks. The beta is 1.06, so SHE:002868's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +189.47% |
| 50-Day Moving Average | 38.93 |
| 200-Day Moving Average | 32.71 |
| Relative Strength Index (RSI) | 55.66 |
| Average Volume (20 Days) | 910,834 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002868 had revenue of CNY 502.95 million and -103.75 million in losses. Loss per share was -0.67.
| Revenue | 502.95M |
| Gross Profit | 37.36M |
| Operating Income | -48.29M |
| Pretax Income | -102.58M |
| Net Income | -103.75M |
| EBITDA | 46.04M |
| EBIT | -48.29M |
| Loss Per Share | -0.67 |
Balance Sheet
The company has 96.01 million in cash and 368.53 million in debt, with a net cash position of -272.52 million or -1.75 per share.
| Cash & Cash Equivalents | 96.01M |
| Total Debt | 368.53M |
| Net Cash | -272.52M |
| Net Cash Per Share | -1.75 |
| Equity (Book Value) | 71.11M |
| Book Value Per Share | 0.46 |
| Working Capital | -176.82M |
Cash Flow
In the last 12 months, operating cash flow was -37.00 million and capital expenditures -123.07 million, giving a free cash flow of -160.08 million.
| Operating Cash Flow | -37.00M |
| Capital Expenditures | -123.07M |
| Depreciation & Amortization | 94.33M |
| Net Borrowing | 274.69M |
| Free Cash Flow | -160.08M |
| FCF Per Share | -1.03 |
Margins
Gross margin is 7.43%, with operating and profit margins of -9.60% and -20.63%.
| Gross Margin | 7.43% |
| Operating Margin | -9.60% |
| Pretax Margin | -20.40% |
| Profit Margin | -20.63% |
| EBITDA Margin | 9.15% |
| EBIT Margin | -9.60% |
| FCF Margin | n/a |
Dividends & Yields
SHE:002868 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.54% |
| Shareholder Yield | 0.54% |
| Earnings Yield | -1.66% |
| FCF Yield | -2.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 28, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |